Miller Anestesia

Asistencia clínica en entornos especiales: bajas y altas presiones y el espacio

2279

Sección IV

Anestesia por subespecialidades en el adulto

174. Hornbein TF, Townes BD, Schoene RB, et al: The

cost to the central nervous system of climbing to

extremely high altitude. N Engl J Med 321:1714–

1719, 1989.

175. Cavaletti G, Tredici G: Effects of exposure to low

oxygen pressure on the central nervous system.

Sports Med 13:1–7, 1992.

176. John AH: The effect of maternal hypoxia on the

heart rate of the foetus in utero. Br J Anaesth

37:515–519, 1965.

177. Polvi HJ, Pirhonen JP, Erkkola RU: The hemodyna-

mic effects of maternal hypo- and hyperoxygena-

tion in healthy term pregnancies. Obstet Gynecol

86:795–799, 1995.

178. Reshetnikova OS, Burton GJ, Milovanov AP: Effects

of hypobaric hypoxia on the fetoplacental unit: The

morphometric diffusing capacity of the villous

membrane at high altitude. Am J Obstet Gynecol

171:1560–1565, 1994.

179. Sobrevilla LA, Cassinelli MT, Carcelen A, Malaga

JM: Human fetal and maternal oxygen tension and

acid-base status during delivery at high altitude. Am

J Obstet Gynecol 111:1111–1118, 1971.

180. Niermeyer S: Cardiopulmonary transition in the

high altitude infant. High Alt Med Biol 4:225–239,

2003.

181. Lahiri S, DeLaney RG, Brody JS, et al: Relative role

of environmental and genetic factors in respiratory

adaptation to high altitude. Nature 261:133–135,

1976.

182. Niermeyer S: Going to high altitude with a newborn

infant. High Alt Med Biol 8:117–123, 2007.

183. Niermeyer S, Andrade P, Vargas E, Moore LG: Pro-

longed postnatal cardiopulmonary transition at

3700-4000 m. High Alt Med Biol 3:439, 2002.

184. Rigatto H, Brady JP: Periodic breathing and apnea

in preterm infants. II. Hypoxia as a primary event.

Pediatrics 50:219–228, 1972.

185. Sartori C, Allemann Y, Trueb L, et al: Augmented

vasoreactivity in adult life associated with perinatal

vascular insult. Lancet 353:2205–2207, 1999.

186. Samuels MP: The effects of flight and altitude. Arch

Dis Child 89:448–455, 2004.

187. Hackett PH, Roach RC: High-altitude illness. N

Engl J Med 345:107–114, 2001.

188. Basnyat B, Murdoch DR: High-altitude illness.

Lancet 361:1967–1974, 2003.

189. Johnson TS, Rock PB: Acute mountain sickness. N

Engl J Med 319:841–845, 1988.

190. Honigman B, Theis MK, Koziol-McLain J, et al:

Acute mountain sickness in a general tourist popu-

lation at moderate altitude. Ann Intern Med

118:587–592, 1993.

191. Larson EB, Roach RC, Schoene RB, Hornbein TF:

Acute mountain sickness and acetazolamide: Clini-

cal efficacy and effect on ventilation. JAMA

248:328–332, 1982.

192. Swenson ER, Hughes JM: Effects of acute and

chronic acetazolamide on resting ventilation

and ventilatory responses in men. J Appl Physiol

74:230–237, 1993.

193. Leaf DE, Goldfarb DS: Mechanisms of action of

acetazolamide in the prophylaxis and treatment

of acute mountain sickness. J Appl Physiol

102:1313–1322, 2007.

194. Rock PB, Johnson TS, Cymerman A, et al: Effect of

dexamethasone on symptoms of acute mountain

sickness at Pikes Peak, Colorado (4,300 m). Aviat

Space Environ Med 58:668–672, 1987.

195. Johnson JS, Rock PB, Fulco CS, et al: Prevention of

acute mountain sickness by dexamethasone. N Engl

J Med 310:683–686, 1984.

196. Gertsch JH, Seto TB, Mor J, Onopa J: Ginkgo biloba

for the prevention of severe acute mountain sick-

ness (AMS) starting one day before rapid ascent.

High Alt Med Biol 3:29–37, 2002.

197. Kenrick PA: Altitude sickness: Gingko biloba does

not prevent altitude sickness. BMJ 327:106, 2003.

198. Beaumont M, Batejat D, Coste O, et al: Effects of

zolpidem and zaleplon on sleep, respiratory pat-

terns and performance at a simulated altitude of

4,000 m. Neuropsychobiology 49:154–162, 2004.

199. Beaumont M, Batejat D, Pierard C, et al: Zaleplon

and zolpidem objectively alleviate sleep disturban-

ces in mountaineers at a 3,613 meter altitude. Sleep

30:1527–1533, 2007.

200. Rios B, Driscoll DJ, McNamara DG: High altitude

pulmonary edema with absent right pulmonary

artery. Pediatrics 75:314–317, 1985.

201. Maggiorini M, Melot C, Pierre S, et al: High-altitude

pulmonary edema is initially caused by an increase

in capillary pressure. Circulation 103:2078–2083,

2001.

202. Schoene RB, Hackett PH, Henderson WR, et al:

High altitude pulmonary edema: Characteristics of

lung lavage fluid. JAMA 256:63–69, 1986.

203. West JB, Mathieu-Costello O: Stress failure of pul-

monary capillaries: Role in lung and heart disease.

Lancet 340:762–767, 1992.

204. Dehnert C, Berger MM, Mairbaurl H, Bartsch P:

High altitude pulmonary edema: A pressure-induced

leak. Respir Physiol Neurobiol 158:266–273, 2007.

205. Bärtsch P, Maggiorini M, Ritter M, et al: Prevention

of high-altitude pulmonary edema by nifedipine. N

Engl J Med 325:1284–1289, 1991.

206. Maggiorini M, Brunner-La Rocca HP, Peth S, et al:

Both tadalafil and dexamethasone may reduce the

incidence of high-altitude pulmonary edema: A

randomized trial. Ann Intern Med 145:497–506,

2006.

207. Sartori C, Allemann Y, Duplain H, et al: Salmeterol

for the prevention of high-altitude pulmonary

edema. N Engl J Med 346:1631–1636, 2002.

208. Jonk AM, van den Berg IP, Olfert IM, et al: Effect of

acetazolamide on pulmonary and muscle gas

exchange during normoxic and hypoxic exercise. J

Physiol 579:909–921, 2007.

209. Oelz O, Maggiorini M, Ritter M, et al: Nifedipine for

high altitude pulmonary oedema. Lancet 2:1241–

1244, 1989.

210. Hackett PH, Roach RC, Hartig GS, et al: The effect

of vasodilators on pulmonary hemodynamics in

high altitude pulmonary edema: A comparison. Int

J Sports Med 13(Suppl 1):S68–S71, 1992.

211. Scherrer U, Vollenweider L, Delabays A, et al:

Inhaled nitric oxide for high-altitude pulmonary

edema. N Engl J Med 334:624–629, 1996.

212. Anand IS, Prasad BA, Chugh SS, et al: Effects of

inhaled nitric oxide and oxygen in high-altitude

pulmonary edema. Circulation 98:2441–2445,

1998.

213. Hackett P, Rennie D: High-altitude pulmonary

edema. JAMA 287:2275–2278, 2002.

214. Larson EB: Positive airway pressure for high-alti-

tude pulmonary oedema. Lancet 1:371–373, 1985.

215. Yarnell PR, Heit J, Hackett PH: High-altitude cere-

bral edema (HACE): The Denver/Front Range

experience. Semin Neurol 20:209–217, 2000.

216. Basnyat B: Isolated facial and hypoglossal nerve

palsies at high altitude. High Alt Med Biol 2:301–

303, 2001.

217. Hackett PH, Yarnell PR, Hill R, et al: High-altitude

cerebral edema evaluated with magnetic resonance

imaging: Clinical correlation and pathophysiology.

JAMA 280:1920–1925, 1998.

218. Kallenberg K, Bailey DM, Christ S, et al: Magnetic

resonance imaging evidence of cytotoxic cerebral

edema in acute mountain sickness. J Cereb Blood

Flow Metab 27:1064–1071, 2007.

219. Leon-Velarde F, Maggiorini M, Reeves JT, et al: Con-

sensus statement on chronic and subacute high alti-

tude diseases. High Alt Med Biol 6:147–157, 2005.

220. Rivera-Ch M, Leon-Velarde F, Huicho L: Treatment

of chronic mountain sickness: Critical reappraisal

of an old problem. Respir Physiol Neurobiol

158:251–265, 2007.

221. Rudge FW: A case of decompression sickness at

2,437 m (8,000 feet). Aviat Space Environ Med

61:1026–1027, 1990.

222. Kumar KV, Waligora JM, Calkins DS: Threshold

altitude resulting in decompression sickness. Aviat

Space Environ Med 61:685–689, 1990.

223. Vann RD, Denoble P, Emmerman MN, Corson KS:

Flying after diving and decompression sickness.

Aviat Space Environ Med 64:801–807, 1993.

224. Varene P, Timbal J, Jacquemin C: Effect of different

ambient pressures on airway resistance. J Appl

Physiol 22:699–706, 1967.

225. Borel C, Simonds D, Guy J, et al: Effect of hypoba-

ricity on hypoxic ventilatory response in humans.

Anesthesiology 85(Suppl):A1121, 1996.

226. Jha SK, Anand AC, Sharma V, et al: Stroke at high

altitude: Indian experience. High Alt Med Biol

3:21–27, 2002.

227. Cucinell SA, Pitts CM: Thrombosis at mountain alti-

tudes. Aviat Space Environ Med 58:1109–1111, 1987.

228. Basnyat B, Wu T, Gertsch JH: Neurological conditions

at altitude that fall outside the usual definition of alti-

tude sickness. High Alt Med Biol 5:171–179, 2004.

229. Maher JT, Levine PH, Cymerman A: Human coagu-

lation abnormalities during acute exposure to hypo-

baric hypoxia. J Appl Physiol 41:702–707, 1976.

230. Bendz B, Rostrup M, Sevre K, et al: Association

between acute hypobaric hypoxia and activation of

coagulation in human beings. Lancet 356:1657–

1658, 2000.

231. Safar P, Tenicela R: High altitude physiology in rela-

tion to anesthesia and inhalation therapy. Anesthe-

siology 25:515–529, 1964.

232. Dickinson JG: Severe acute mountain sickness.

Postgrad Med J 55:454–460, 1979.

233. Camporesi EM: Anesthesia at different environ-

mental pressures.

Ehrenwerth J, Eisenkraft JB

(eds): Anesthesia Equipment. St. Louis, Mosby-Year

Book, 1993, pp 588–598.

234. James MFM, White JF: Anesthetic considerations at

moderate altitude. Anesth Analg 63:1097–1105, 1984.

235. Röggla G, Röggla H, Röggla M, et al: Effect of

alcohol on acute ventilatory adaptation to mild

hypoxia at moderate altitude. Ann Intern Med

122:925–927, 1995.

236. Röggla G, Moser B, Röggla M: Effect of temazepam

on ventilatory response at moderate altitude. BMJ

320:56, 2000.

237. Dubowitz G: Effect of temazepam on oxygen satu-

ration and sleep quality at high altitude: Randomi-

sed placebo controlled crossover trial. BMJ

316:587–589, 1998.

238. James MFM, Manson EDM, Dennett JE: Nitrous

oxide analgesia and altitude. Anaesthesia 37:285–

288, 1982.

239. Nunn JF: Anaesthesia at altitude. In Ward MP,

Milledge JS, West JB (eds): High Altitude Medicine

and Physiology. London, Chapman and Hall

Medical, 1989, pp 481–486.

240. Pederson L, Benumof J: Incidence and magnitude

of hypoxaemia with ketamine in a rural African

hospital. Anaesthesia 48:67–69, 1993.

241. Bishop RA, Litch JA, Stanton JM: Ketamine anesthesia

at high altitude. High Alt Med Biol 1:111–114, 2000.

242. Grocott MP, Johannson L: Ketamine for emergency

anaesthesia at very high altitude (4243 m above sea-

level). Anaesthesia 62:959–962, 2007.

243. Puri GD, Jayant A, Dorje M, Tashi M: Propofol-

fentanyl anaesthesia at high altitude: Anaesthetic

requirements and haemodynamic variations when

compared with anaesthesia at low altitude. Acta

Anaesthesiol Scand 52:427–431, 2008.